Treace to Present at the 41st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023
December 20, 2022 16:15 ET
|
Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., Dec. 20, 2022 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the...
Treace Medical Announces Expansion of Its Global IP Portfolio with the Grant of Two New U.S. Patents
December 19, 2022 16:15 ET
|
Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., Dec. 19, 2022 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace Medical” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in...
Treace Receives FDA 510(k) Clearance for SpeedPlate™ Rapid Compression Implant Technology
November 28, 2022 16:15 ET
|
Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., Nov. 28, 2022 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the...
Treace Announces First Patient Treated in MTA3D™ Adductoplasty® Clinical Study
November 21, 2022 16:15 ET
|
Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., Nov. 21, 2022 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of...
Treace Medical Concepts Reports Third Quarter 2022 Financial Results
November 08, 2022 16:05 ET
|
Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., Nov. 08, 2022 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the...
Treace Announces Participation in Upcoming Investor Conferences
October 25, 2022 16:15 ET
|
Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., Oct. 25, 2022 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of...
Treace to Report Third Quarter 2022 Financial Results on November 8, 2022
October 18, 2022 16:15 ET
|
Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., Oct. 18, 2022 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of...
Treace Medical Concepts Appoints New Directors
September 27, 2022 16:15 ET
|
Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., Sept. 27, 2022 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the...
Treace Highlights New Product Innovations at the 2022 AOFAS Scientific Conference
September 13, 2022 16:15 ET
|
Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., Sept. 13, 2022 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the...
Treace Announces Updated ALIGN3D™ Data at the 2022 AOFAS Annual Meeting
September 13, 2022 16:05 ET
|
Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., Sept. 13, 2022 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of...